Cargando…

Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy

The recurrence rate of choledocholithiasis in the general population has been reported to exceed 10%. The incidence of cholelithiasis was reported to be higher in patients following gastrectomy than that in the general population. However, there is no study for recurrent choledocholithiasis incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kweon, O Seong, Heo, Jun, Jung, Min Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453114/
https://www.ncbi.nlm.nih.gov/pubmed/37627910
http://dx.doi.org/10.3390/diagnostics13162651
_version_ 1785095843198533632
author Kweon, O Seong
Heo, Jun
Jung, Min Kyu
author_facet Kweon, O Seong
Heo, Jun
Jung, Min Kyu
author_sort Kweon, O Seong
collection PubMed
description The recurrence rate of choledocholithiasis in the general population has been reported to exceed 10%. The incidence of cholelithiasis was reported to be higher in patients following gastrectomy than that in the general population. However, there is no study for recurrent choledocholithiasis incidence in patients following gastrectomy. This study aimed to evaluate the recurrence rate of choledocholithiasis and identify risk factors for recurrent choledocholithiasis in patients following gastrectomy. A retrospective analysis was performed on patients with gastrectomy history who underwent choledocholithiasis removal in Kyungpook National University Hospital between January 2011 and December 2019. Choledocholithiases were treated by endoscopic retrograde cholangiopancreatography (ERCP) (n = 41) or percutaneous transhepatic biliary drainage (PTBD) (n = 90). The gastrectomy type was classified as subtotal gastrectomy with Billroth I (18.3%), Billroth II (45.0%), and total gastrectomy with Roux-en-Y (36.6%). During a median follow-up period of 31.5 (range, 6–105) months, choledocholithiasis recurrence was noted in 19 of 131 patients (14.5%). In subgroup analysis, the ERCP group (24.4%) had higher choledocholithiasis recurrence than the PTBD group (10.0%). Stone removal modality (ERCP), no use of balloon sphincteroplasty, and the presence of periampullary diverticulum were significant risk factors for recurrent choledocholithiasis. In multivariate analysis, ERCP (hazard ratio (HR), 3.597; 95% confidence interval (CI): 1.264–10.204) CBD stricture (HR, 3.823; 95% CI: 1.118–13.080) and no use of balloon sphincteroplasty (HR, 4.830; 95% CI: 1.669–13.889) were risk factors for recurrent choledocholithiasis following stone removal. The incidence of CBD stones in patients who underwent gastrectomy is similar to that of the general population. ERCP, CBD stricture, and no use of balloon sphincteroplasty are potential risk factors for recurrent CBD stones following gastrectomy. When we consider PTBD disadvantages, the ERCP procedure with active use of balloon sphincteroplasty is recommended to decrease recurrent CBD stones.
format Online
Article
Text
id pubmed-10453114
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104531142023-08-26 Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy Kweon, O Seong Heo, Jun Jung, Min Kyu Diagnostics (Basel) Article The recurrence rate of choledocholithiasis in the general population has been reported to exceed 10%. The incidence of cholelithiasis was reported to be higher in patients following gastrectomy than that in the general population. However, there is no study for recurrent choledocholithiasis incidence in patients following gastrectomy. This study aimed to evaluate the recurrence rate of choledocholithiasis and identify risk factors for recurrent choledocholithiasis in patients following gastrectomy. A retrospective analysis was performed on patients with gastrectomy history who underwent choledocholithiasis removal in Kyungpook National University Hospital between January 2011 and December 2019. Choledocholithiases were treated by endoscopic retrograde cholangiopancreatography (ERCP) (n = 41) or percutaneous transhepatic biliary drainage (PTBD) (n = 90). The gastrectomy type was classified as subtotal gastrectomy with Billroth I (18.3%), Billroth II (45.0%), and total gastrectomy with Roux-en-Y (36.6%). During a median follow-up period of 31.5 (range, 6–105) months, choledocholithiasis recurrence was noted in 19 of 131 patients (14.5%). In subgroup analysis, the ERCP group (24.4%) had higher choledocholithiasis recurrence than the PTBD group (10.0%). Stone removal modality (ERCP), no use of balloon sphincteroplasty, and the presence of periampullary diverticulum were significant risk factors for recurrent choledocholithiasis. In multivariate analysis, ERCP (hazard ratio (HR), 3.597; 95% confidence interval (CI): 1.264–10.204) CBD stricture (HR, 3.823; 95% CI: 1.118–13.080) and no use of balloon sphincteroplasty (HR, 4.830; 95% CI: 1.669–13.889) were risk factors for recurrent choledocholithiasis following stone removal. The incidence of CBD stones in patients who underwent gastrectomy is similar to that of the general population. ERCP, CBD stricture, and no use of balloon sphincteroplasty are potential risk factors for recurrent CBD stones following gastrectomy. When we consider PTBD disadvantages, the ERCP procedure with active use of balloon sphincteroplasty is recommended to decrease recurrent CBD stones. MDPI 2023-08-11 /pmc/articles/PMC10453114/ /pubmed/37627910 http://dx.doi.org/10.3390/diagnostics13162651 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kweon, O Seong
Heo, Jun
Jung, Min Kyu
Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title_full Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title_fullStr Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title_full_unstemmed Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title_short Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
title_sort comparison study between ercp and ptbd for recurrent choledocholithiasis in patients following gastrectomy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453114/
https://www.ncbi.nlm.nih.gov/pubmed/37627910
http://dx.doi.org/10.3390/diagnostics13162651
work_keys_str_mv AT kweonoseong comparisonstudybetweenercpandptbdforrecurrentcholedocholithiasisinpatientsfollowinggastrectomy
AT heojun comparisonstudybetweenercpandptbdforrecurrentcholedocholithiasisinpatientsfollowinggastrectomy
AT jungminkyu comparisonstudybetweenercpandptbdforrecurrentcholedocholithiasisinpatientsfollowinggastrectomy